Celyad Oncology Stock Forecast, Price & News

Celyad Oncology (NASDAQ:CYAD) Frequently Asked Questions

Is Celyad Oncology a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Celyad Oncology in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Celyad Oncology stock.
View analyst ratings for Celyad Oncology or view top-rated stocks.

How has Celyad Oncology's stock been impacted by Coronavirus?

Celyad Oncology's stock was trading at $7.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CYAD stock has decreased by 53.2% and is now trading at $3.67.
View which stocks have been most impacted by COVID-19.

Are investors shorting Celyad Oncology?

Celyad Oncology saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 7,200 shares, a drop of 60.0% from the October 31st total of 18,000 shares. Based on an average daily trading volume, of 24,100 shares, the days-to-cover ratio is presently 0.3 days.
View Celyad Oncology's Short Interest.

What price target have analysts set for CYAD?

2 brokers have issued 12 month price targets for Celyad Oncology's shares. Their forecasts range from $15.00 to $15.00. On average, they expect Celyad Oncology's share price to reach $15.00 in the next year. This suggests a possible upside of 308.7% from the stock's current price.
View analysts' price targets for Celyad Oncology or view top-rated stocks among Wall Street analysts.

Who are Celyad Oncology's key executives?

Celyad Oncology's management team includes the following people:

• Filippo Joseph Petti, Director, Chief Executive & Financial Officer
• Frederic Lehmann, VP-Clinical Development & Medical Affairs
• David Gilham, Chief Scientific Officer
• Peggy Sotiropoulou, Head-Research & Development
• Charles Q. Morris, Chief Medical Officer

Who are some of Celyad Oncology's key competitors?

Some companies that are related to Celyad Oncology include Matinas BioPharma (MTNB), Clearside Biomedical (CLSD), Avalo Therapeutics (AVTX), Wave Life Sciences (WVE), Ampio Pharmaceuticals (AMPE), Vincerx Pharma (VINC), DURECT (DRRX), Esperion Therapeutics (ESPR), Immunic (IMUX), Antibe Therapeutics (ATBPD), Leap Therapeutics (LPTX), AVEO Pharmaceuticals (AVEO), Tonix Pharmaceuticals (TNXP), Ovid Therapeutics (OVID) and Impel NeuroPharma (IMPL).
View all of CYAD's competitors.

What other stocks do shareholders of Celyad Oncology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celyad Oncology investors own include Galapagos (GLPG), Cellectis (CLLS), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), ChromaDex (CDXC), bluebird bio (BLUE), SCYNEXIS (SCYX), Neurocrine Biosciences (NBIX), AbbVie (ABBV) and argenx (ARGX).

When did Celyad Oncology IPO?

(CYAD) raised $99 million in an IPO on Friday, June 19th 2015. The company issued 1,400,000 shares at $70.98 per share. UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Petercam Bryan, Garnier, LifeSci Capital and Lake Street Capital Markets were co-managers.

What is Celyad Oncology's stock symbol?

Celyad Oncology trades on the NASDAQ under the ticker symbol "CYAD."

How do I buy shares of Celyad Oncology?

Shares of CYAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Celyad Oncology's stock price today?

One share of CYAD stock can currently be purchased for approximately $3.67.

How much money does Celyad Oncology make?

Celyad Oncology has a market capitalization of $59.06 million and generates $10 thousand in revenue each year.

How many employees does Celyad Oncology have?

Celyad Oncology employs 83 workers across the globe.

What is Celyad Oncology's official website?

The official website for Celyad Oncology is www.celyad.com.

Where are Celyad Oncology's headquarters?

Celyad Oncology is headquartered at RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT C9, 1435.

How can I contact Celyad Oncology?

Celyad Oncology's mailing address is RUE EDOUARD BELIN 12, MONT-SAINT-GUIBERT C9, 1435. The company can be reached via phone at (210) 039-4100 or via fax at 321-039-4141.